Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
VP-001 by PYC Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
VP-001 is under clinical development by PYC Therapeutics and currently in Phase I for Retinitis Pigmentosa (Retinitis). According to GlobalData,...
Data Insights
Methotrexate by Aldeyra Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Methotrexate is under clinical development by Aldeyra Therapeutics and currently in Phase II for Retinitis Pigmentosa (Retinitis). According to GlobalData,...